PROSTATE-SPECIFIC ANTIGEN : Its Discovery and Biochemical Characteristics - 11/09/11
Résumé |
The search for a tumor marker more sensitive and specific for prostate cancer than prostatic acid phosphatase led to the discovery more than two decades ago of several prostate antigens that subsequently became known as prostate-specific antigen (PSA). Today, PSA is recognized as the best tumor marker for prostate cancer. In 1996, 317,000 new cases of prostate cancer were diagnosed,46 in part due to the utilization of the PSA assay as well as the awareness of the test and the disease among the general public. PSA's clinical importance is underscored by the fact that early detection of prostate cancer affords a potential cure. This article focuses on the discovery of PSA and describes some of its biochemical characteristics.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Daniel W. Chan, PhD, DABCC, Department of Pathology, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Meyer B–121, Baltimore, MD 21287–7065 |
Vol 24 - N° 2
P. 253-259 - mai 1997 Retour au numéro
Article précédent
- DEFINING THE IDEAL TUMOR MARKER FOR PROSTATE CANCER
- James E. Montie, Stephanie E. Meyers
- ISSUES IN THE ASSESSMENT OF PROSTATE-SPECIFIC ANTIGEN IMMUNOASSAYS : An Update
- Robert L. Vessella, Paul H. Lange
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?